SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.29 revenue of $3.99M August, 11 2022 05:03 PM Sonoma Pharmaceuticals Inc. Sonoma Pharmaceuticals press release ( NASDAQ: SNOA ): Q1 GAAP EPS of -$0.29. Revenue of $3.99M (+8.4% Y/Y). For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.29, revenue of $3.99M